
CryoPort (CYRX) Stock Forecast & Price Target
CryoPort (CYRX) Analyst Ratings
Bulls say
CryoPort is well-positioned in a growing market for temperature-controlled supply chain solutions, with a focus on the cell and gene therapy industry. The company's diversified services and products business segments provide multiple revenue streams and potential for cross-selling opportunities. Additionally, the company's strong revenue visibility and potential for margin expansion make it an attractive investment opportunity.
Bears say
CryoPort is a high-growth company that operates in the growing cell and gene therapy market, but is facing tough comps and slowing growth in its Life Sciences Products segment. Furthermore, its valuation seems stretched compared to its peers, and it may struggle to reach profitability in the near term with a low adjusted EBITDA margin. Additionally, upcoming BLA/MAA filings and approvals may provide some potential upside, but overall, we remain cautious on the stock due to these challenges.
This aggregate rating is based on analysts' research of CryoPort and is not a guaranteed prediction by Public.com or investment advice.
CryoPort (CYRX) Analyst Forecast & Price Prediction
Start investing in CryoPort (CYRX)
Order type
Buy in
Order amount
Est. shares
0 shares